7W8-31335-17114
2 vaccinations
7 coded responses
19 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 773 / TX
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-05
Registered in v-safe
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-06
- 2021-03-07
- 2021-03-08
-
2021-03-09
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue, Pre-existing disease — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: I have multiple comorbidities that could count for fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: I have medical conditions that make me fatigued.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Survey response — day 7, dose 1MedDRA: Fatigue — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: I have other conditions that make me tired.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-18
- 2021-03-25
-
2021-03-27
Dose 2 — Pfizer-BioNTech
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Blood pressure increased — Feeling: Fair · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Blood pressure issues: crisis level when standing; dangerous when seated and elevated when laying downMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Erythema, Feeling hot, Flushing, Pre-existing disease, Swelling face — Feeling: Fair · Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Have red hot facial swelling and flushing due to MCAS flareMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — day 7, dose 2MedDRA: General symptom, Pre-existing disease — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: I have comorbidities that can account for these symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-02
- 2021-05-08
- 2021-09-25
-
2022-03-27
Survey response — 12 months, dose 2MedDRA: Fatigue, Migraine, Orthostatic hypotension, Vertigo — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Vertigo, migraines, fatigue, orthostatic hypotensionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): I have multiple comorbidities that could count for fatigue.
Systemic reaction (other): I have medical conditions that make me fatigued.
Release 5 — day 7, dose 1
Systemic reaction (other): I have other conditions that make me tired.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Blood pressure issues: crisis level when standing; dangerous when seated and elevated when laying down
Systemic reaction (other): Have red hot facial swelling and flushing due to MCAS flare
Release 6 — day 7, dose 2
Systemic reaction (other): I have comorbidities that can account for these symptoms
Release 11 — 12 months, dose 2
Symptoms: Vertigo, migraines, fatigue, orthostatic hypotension
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Orthostatic hypotension | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Blood pressure increased | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
| SRO | General symptom | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Swelling face | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release